Edwards Lifesciences to Present at the 44th Annual J.P. Morgan Healthcare Conference

Edwards Lifesciences Corporation (NYSE: EW) today announced it will participate in the J.P. Morgan Healthcare Conference on Monday, Jan. 12, 2026.

Bernard Zovighian, chief executive officer, is scheduled to present at 11:15 a.m. PT. Scott Ullem, chief financial officer, will also participate in the conference. A live webcast of the presentation will be available on the Edwards Lifesciences investor relations website at http://ir.edwards.com/, with an archived version accessible later the same day.

About Edwards Lifesciences

Edwards Lifesciences is the leading global structural heart innovation company, driven by a passion to improve patient lives. Through breakthrough technologies, world-class evidence and partnerships with clinicians and healthcare stakeholders, our employees are inspired by our patient-focused culture to deliver life-changing innovations to those who need them most. Discover more at www.edwards.com and follow us on LinkedIn, Facebook, Instagram and YouTube.

Edwards, Edwards Lifesciences, and the stylized E logo are trademarks of Edwards Lifesciences Corporation. All other trademarks are the property of their respective owners.

Contacts

More News

View More

Recent Quotes

View More
Symbol Price Change (%)
AMZN  226.76
+5.49 (2.48%)
AAPL  272.19
+0.35 (0.13%)
AMD  200.98
+2.87 (1.45%)
BAC  54.26
-0.29 (-0.53%)
GOOG  303.75
+5.69 (1.91%)
META  664.45
+14.95 (2.30%)
MSFT  483.98
+7.86 (1.65%)
NVDA  174.14
+3.20 (1.87%)
ORCL  180.03
+1.57 (0.88%)
TSLA  483.37
+16.11 (3.45%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.